Certified by Founder Lodge
LabGenius
United Kingdom - London, UK
START UP
1 Disclosed Funding Rounds $44,609,250
0 Participating Investments
-
Founded date
2012
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
LabGenius is the first biopharmaceutical company developing next generation protein therapeutics using a machine learning-driven evolution engine (EVA™).
Our protein engineering platform i
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 22 ,2024 | Series B | $44,609,250 |
Octopus Ventures
Kindred Capital VC
Atomico
Obvious Ventures
M Ventures(Netherlands)
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
